Stress News and Research

RSS

New report provides detailed criteria for rational and timely use of cardiac catheterization

A new report issued today by the American College of Cardiology Foundation (ACCF) and the Society for Cardiovascular Angiography and Interventions (SCAI) in collaboration with a dozen other professional societies provides detailed criteria to help clinicians determine when cardiac catheterization is a reasonable option for the evaluation of patients for heart disease.

10 May 2012

Caffeine consumption: How much is too much?

Chocolate, coffee and cola are perhaps three of your favourite consumables; however, they are also three caffeine-rich substances which all contribute to your daily caffeine consumption. According to the BBC, people should not exceed 400mg caffeine a day, and this limit halves for pregnant women, for which only 200mg/day is recommended.

10 May 2012

Study identifies five factors that promote positive body image in women

Women with high family support and limited pressure to achieve the 'thin and beautiful' ideal have a more positive body image. That's according to a new study looking at five factors that may help young women to be more positive about their bodies, in the context of a society where discontent with appearance is common among women.

10 May 2012

UAB’s First Episode Schizophrenia Clinic rapidly treats patients with new diagnosis

Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.

10 May 2012

ACOEM honors JNJ with 2012 Corporate Health Achievement Award

Johnson & Johnson (JNJ) the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services for the consumer and pharmaceutical and medical devices and diagnostics markets, has been awarded the 2012 Corporate Health Achievement Award (CHAA) by the American College of Occupational and Environmental Medicine.

10 May 2012

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.

9 May 2012

eTNS therapy can impact symptoms in pharmacoresistant major depression

9 May 2012

Caring for carers

According to a new poll, there are hundreds of thousands of unpaid carers in Scotland who are suffering from mental health problems and struggling to keep their jobs.

8 May 2012

Ritalin use in ADHD rises four-fold over a decade

According to latest figures prescriptions for Ritalin for attention deficit hyperactivity disorder (ADHD) have quadrupled in a decade. This has raised concerns that it is being given to children at the expense of alternative treatments and without appreciation of long-term effects.

8 May 2012

BCBSMA institutes enhanced safety measures on coverage for powerful pain killers

In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.

8 May 2012

DFG to establish seven new research units

The establishment of six new Research Units and one Clinical Research Unit has been decided by the Joint Committee of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). These networks will offer researchers the opportunity to address current and pressing issues in their fields and to pioneer innovative approaches. As all DFG Research Units, the new groups will work across locations and disciplines. Clinical Research Units combine clinical, applied and basic research.

8 May 2012

Brief empathy training program improves resident physicians interactions with patients

Resident physicians' participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.

8 May 2012

Breast brachytherapy with strut-based applicator effective for women with DCIS

Breast brachytherapy with a strut-based applicator appears to be an effective treatment for women who have ductal carcinoma in situ (DCIS) of the breast, according to a groundbreaking study presented at the annual meeting of the American Society of Breast Surgeons, held in Phoenix May 2-4.

8 May 2012

PAR releases latest edition of Parenting Stress Index

PAR, Inc. has released the latest edition of its popular Parenting Stress Index.

8 May 2012

New analysis on why some soldiers never seek PTSD care

U.S. Army researcher Maj. Gary H. Wynn, M.D., shared new analysis on why some Soldiers suffering from combat-related post-traumatic stress disorder (PTSD) never seek care or drop out of treatment early during a presentation today at the American Psychiatric Association's annual meeting. His presentation, "Epidemiology of Combat-Related PTSD in U.S. Service Members: Lessons Learned," also described the approaches the Army is using to address this issue and improve overall patient outcomes.

8 May 2012

Rare form of dementia eats away at personality and language

Michael French suffered from a rare form of dementia. It made him do unwise things like throwing away tax documents, getting a ticket for trying to pass an ambulance and buying stock in companies that were obviously in trouble. He seemed withdrawn and no longer spoke to his wife over dinner. He also lost his job at the consulting firm. This happened in 2006. His wife found he had changed suddenly from the smart, good-natured, hardworking man and was considering divorce when his ailment came into the picture.

8 May 2012

New information about biological outcomes and commuting distance

As populations move even further away from urban centers, more people spend longer hours behind the wheel on their way to and from work. While sedentary behavior is known to have adverse effects on cardiovascular and metabolic health, the impact of long commutes by automobile are less understood. A new study has found that greater commuting distances are associated with decreased cardiorespiratory fitness (CRF), increased weight, and other indicators of metabolic risk.

8 May 2012

Everett Labs announces availability of Pregnitude for women with fertility problems

A new non-prescription Reproductive Support Dietary Supplement, Pregnitude, which contains myo-inositol (2 g), plus folic acid (200 mcg), is now available for women who are having difficulty conceiving, Everett Laboratories announced today. In clinical studies, Pregnitude has been shown to help support ovulation function and menstrual cycle regularity as well as support the quality of a woman's eggs.

8 May 2012

Cigna encourages new mothers to get screened for prenatal and postpartum depression

A mother's emotional health is as important as her physical health during pregnancy and after delivery. That's why, during May, Maternal Depression Awareness Month, Cigna (NYSE: CI) is encouraging soon-to-be and new mothers to get screened and understand the symptoms of prenatal and postpartum depression.

8 May 2012

New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

8 May 2012

Stress News and Research

New report provides detailed criteria for rational and timely use of cardiac catheterization

Caffeine consumption: How much is too much?

Study identifies five factors that promote positive body image in women

UAB’s First Episode Schizophrenia Clinic rapidly treats patients with new diagnosis

ACOEM honors JNJ with 2012 Corporate Health Achievement Award

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

eTNS therapy can impact symptoms in pharmacoresistant major depression

Caring for carers

Ritalin use in ADHD rises four-fold over a decade

BCBSMA institutes enhanced safety measures on coverage for powerful pain killers

DFG to establish seven new research units

Brief empathy training program improves resident physicians interactions with patients

Breast brachytherapy with strut-based applicator effective for women with DCIS

PAR releases latest edition of Parenting Stress Index

New analysis on why some soldiers never seek PTSD care

Rare form of dementia eats away at personality and language

New information about biological outcomes and commuting distance

Everett Labs announces availability of Pregnitude for women with fertility problems

Cigna encourages new mothers to get screened for prenatal and postpartum depression

New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News